REG - Induction Healthcare - Notice of Half-year Results

Induction HealthcareAnnouncement

26/11/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211126:nRSZ6559Ta&default-theme=true

RNS Number : 6559T  Induction Healthcare Group PLC   26 November 2021

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Notice of Half-year Results

 

Induction (AIM: INHC), a leading virtual care platform driving digital
transformation of healthcare systems worldwide, will announce its interim
results for the six months ended 30 September 2021 on Thursday 2 December
2021.

 

Analyst Briefing

A briefing for equity analysts will take place on Thursday 2 December 2021 at
09:30 GMT. For further details analysts should email induction@walbrookpr.com
or call +44 (0)20 7933 8785.

 

Investor Briefing

James Balmain, Chief Executive Officer and Guy Mitchell, Chief Financial
Officer will be hosting a live online presentation relating to the interim
results via the Investor Meet Company platform at 15:00 GMT on Thursday 2
December. The presentation is open to all existing and potential shareholders.

 

Investors can sign up to Investor Meet Company for free and register for the
presentation here:
https://www.investormeetcompany.com/induction-healthcare-group-plc/register-investor
(https://www.investormeetcompany.com/induction-healthcare-group-plc/register-investor)
 

 

Investors who already follow Induction on the Investor Meet Company platform
will automatically be invited.

 

Questions can be submitted pre-event via your IMC dashboard or in real time
during the presentation, via the "Ask a Question" function. Whilst the
Company may not be in a position to answer every question it receives, it will
address the most prominent within the confines of information already
disclosed to the market through regulatory notifications. A recording of the
presentation, a PDF of the slides used, and responses to the Q&A session
will be available on the Investor Meet Company platform afterwards.

 

 

ENQUIRIES

 

 Induction                                              Via Walbrook PR Ltd: induction@walbrookpr.com

 James Balmain, Chief Executive Officer

 Dr Hugo Stephenson, Group Executive Director

 Singer Capital Markets (Nominated Adviser and Broker)  +44 (0) 20 7496 3000
 Philip Davies / Kailey Aliyar

 Walbrook PR Ltd                                        induction@walbrookpr.com
 Paul McManus / Alice Woodings                          Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

About Induction -  www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

 

Induction (AIM: INHC) is a leading virtual care platform driving digital
transformation of healthcare systems worldwide. Induction solutions enhance
the investments hospitals have made and lay the foundation for their future.
Our products can enable information sharing between busy doctors, alleviate
operational burdens on hospitals or put patients in better control of their
care, all while ensuring the highest standards of clinical safety and
information security. We unchain staff and patients from the limitations of
paper-based and desktop systems, creating substantial time and cost
efficiencies.

 

More than 225,000 hospital doctors across multiple territories, including the
UK, Ireland, Australia and South Africa, as well as a rapidly growing number
of more than 300,000 UK patients, choose Induction solutions.

 

Induction Switch is the number one healthcare collaboration app in the UK,
used by the majority of hospital doctors within the NHS. The app helps to
increase productivity and enhance communication by securely sharing phone
numbers and bleeps, bookmarks, documents and messages in a clinical setting.

 

Induction Guidance provides medical organisations, including most hospital
trusts within the NHS, with the ability to collaboratively create, edit, and
publish their own local medical guidelines in a secure and locally
administrated environment. This increases knowledge of, and adherence to,
guidance.

 

Induction Zesty is a market-leading digital platform for patients visiting
hospitals. The platform allows patients to book and access their appointments,
read their clinical letters, store a copy of their clinical record and provide
data to their care teams remotely. It is not just a compelling patient
experience, but also delivers significant cost benefits to hospitals.

 

Induction Attend Anywhere is the UK market leader in secondary care video
consultations. It helps hospitals, health systems and other customers offer
video consultations to patients and service users as a normal part of
day-to-day clinical activity. Our vision is for video consultations to improve
lives and help address social, access, equity and sustainability challenges by
allowing healthcare providers to determine how and when they see a patient
based on each individual case: in-person, via video or on the telephone.

 

Induction HealthStream is a proprietary data integration platform that reads
and writes patient demographic, appointment and clinical record data between a
growing number of hospital EHR systems and the Induction platforms. This
connectivity between stakeholders and legacy IT systems adds substantial value
to pre-existing health IT investment and allows large-scale adoption of
Induction app-based services.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORPPGPWGUPGGMA